cov    pid  1 [        .         .         .         .         :         .         .         . 80 
 1 AIP_KSAH/1     100.0% 100.0%    ATYEVLCEVARK-LGTDDREVVLFLL---NVFIPQPT---LAQLIGALRALKEEGRL---TFPLLAECLFRAGRRDLLRD    
 2 AIP_KSAH/2      98.6%  16.5%    SPYQLTVLHVDGELCARDIRSLIFLS---KDTIGSRSTP--QTFLHWVYCMENLDLLGPTDVDALMSMLRSLSRVDLQRQ    
 3 ORFE8_EH2/1     97.3%  24.0%    SHYSMIDTYFS--LDEDETETYLYLC----RDLLKNKGE-FQCTRDAFKFLSDYACL---SAANQMELLFRVGRLDLIRR    
 4 ORFE8_EH2/2    100.0%  17.3%    SPFRCLMALVNDFLSDKEVEEMYFLC--APRLESHLEPGSKKSFLRLASLLEDLELLGGDKLTFLRHLLTTIGRADLVKN    
 5 Mch4_HUMAN/1   100.0%  21.2%    VSFREKLLIIDSNLGVQDVENLKFLC---IGLVPNKKLEKSSSASDVFEHLLAEDLLSEEDPFFLAELLYIIRQKKLLQH    
 6 Mch4_HUMAN/2    98.6%  13.0%    SLFRNLLYELSEGIDSENLKDMIFLL---KDSLPKT----EMTSLSFLAFLEKQGKIDEDNLTCLEDLCKTVVPKLLRNI    
 7 MACHa2_HUMAN/2 100.0%  12.5%    SAYRVMLYQISEEVSRSELRSFKFLL---QEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRVCAQINKSLLKII    
 8 Mch5a_HUMAN/1  100.0%  25.0%    MDFSRNLYDIGEQLDSEDLASLKFLS---LDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLKELLFRINRLDLLIT    
 9 CASHa_MOUSE/2  100.0%  18.1%    SDYRVLLMEIGESLDQNDVSSLVFLTRITRDYTGRGKIAKDKSFLDLVIELEKLNLIASDQLNLLEKCLKNIHRIDLNTK    
10 KE05_HUMAN     100.0%  21.2%    YSLHRMFDIVGTHLTHRDVRVLSFLF---VDVIDDHERGLIRNGRDFLLALERQGRCDESNFRQVLQLLRIITRHDLLPY    
11 FAP_HUMAN      100.0%  21.2%    DPFLVLLHSVSSSLSSSELTELKFLC---LGRVGKRKLERVQSGLDLFSMLLEQNDLEPGHTELLRELLASLRRHDLLRR    
12 MC159L_MCV1/1   97.3%  23.3%    PSLPFLRHLLEE-LDSHEDSLLLFLC----HDAAPGC----TTVTQALCSLSQQRKL---TLAALVEMLYVLQRMDLLKS    
13 MC159L_MCV1/2  100.0%  17.1%    TRYRKLMVCVGEELDSSELRALRLFACNLNPSLSTALSE-SSRFVELVLALENVGLVSPSSVSVLADMLRTLRRLDLCQQ    
14 MC160L/1        97.3%  26.0%    IPFSFLRNLLAE-LDASEHEVLRFLC----RDVAPAS----KTAEDALRALQRRRLL---TLSSMAELLCALRRFDVLKV    
15 MC160L/2        98.6%  19.0%    SQYRLQVAAINNMVGSEDLRVMCLCA---GKLLPPSCTP--RCLVDLVSALEDAGAISPQDVSVLVTLLHAVCRYDLSVA    
16 FLIP_SH2        97.3%  16.9%    MDLKTTVLHITDSFTEEEMYCLLFLI---NGCIPRN-----CNAVKISDLIIETLSKSTQWDICLTQCLYVLRKIELLLN    
17 FLICEl_MOUSE    98.6%  33.8%    VSAEVIHQVEEC-LDEDEKEMMLFLC----RDVTENLA--APNVRDLLDSLSERGQL---SFATLAELLYRVRRFDLLKR    
18 PEID_HUMAN     100.0%  16.2%    AEYGTLLQDLTNNITLEDLEQLKSAC---KEDIPSEKSEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISRRPDLLTM    
   consensus/100%                  ..h.......t..hs.pp...h..h.................p...h...h.t...h.........phh.......l...    
   consensus/90%                   ..h...h..htt.ls.p-ht.hhhh.......hs........ph.thh..h.p...h...p...h.phhh.htp..L...    
   consensus/80%                   ..hphhh..lsp.lstp-hp.hhaLh....t.lspt.....tshhphh..Lpp.thl...phthlhphLh.lt+h-Lh..    
   consensus/70%                   ssaphhhh.lsp.Lspp-hcshhFLs....c.lsptp....pshhchhthLpctshlt.tshshLtchLhtlpRhDLhpt    

                     cov    pid 81   ] 83 
 1 AIP_KSAH/1     100.0% 100.0%    LLH    
 2 AIP_KSAH/2      98.6%  16.5%    VQT    
 3 ORFE8_EH2/1     97.3%  24.0%    IFG    
 4 ORFE8_EH2/2    100.0%  17.3%    LQV    
 5 Mch4_HUMAN/1   100.0%  21.2%    LNC    
 6 Mch4_HUMAN/2    98.6%  13.0%    EKY    
 7 MACHa2_HUMAN/2 100.0%  12.5%    NDY    
 8 Mch5a_HUMAN/1  100.0%  25.0%    YLN    
 9 CASHa_MOUSE/2  100.0%  18.1%    IQK    
10 KE05_HUMAN     100.0%  21.2%    VTL    
11 FAP_HUMAN      100.0%  21.2%    VDD    
12 MC159L_MCV1/1   97.3%  23.3%    RFG    
13 MC159L_MCV1/2  100.0%  17.1%    LVE    
14 MC160L/1        97.3%  26.0%    RFG    
15 MC160L/2        98.6%  19.0%    LSA    
16 FLIP_SH2        97.3%  16.9%    LFQ    
17 FLICEl_MOUSE    98.6%  33.8%    ILK    
18 PEID_HUMAN     100.0%  16.2%    VVD    
   consensus/100%                  ...    
   consensus/90%                   ...    
   consensus/80%                   h..    
   consensus/70%                   l.t